Course Information

Opioids for Chronic Non-Cancer Pain: Using the Canadian Guideline in Your Practice

Opioids for Chronic Non-Cancer Pain: Using the Canadian Guideline in Your Practice

Canadian physicians and medical regulators continue to need guidance regarding opioid use for chronic non-cancer pain.

In 2010, the National Opioid Use Guideline Group offered recommendations for safe and effective use of opioids. Despite the implementation of the guidelines being associated with a decline in opioid use, critics characterized the recommendations as containing little direction about when not to prescribe or when to limit doses or duration of therapy.

The 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain attempts to address these concerns by adhering to current best practices for systematic reviews and guideline development and incorporating evidence published since that used to inform the 2010 guideline. The 2017 guideline provides strong or weak recommendations when evidence is consistent, and best practice statements and expert guidance when evidence is conflicting or absent.

The recommendations in the 2017 Canadian Guideline will assist physicians and other health care providers to use opioids effectively and safely in patients with chronic non-cancer pain. The best practice and expert guidance statements will also help physicians inform patients about the potential benefits and risks of opioids, and enable other healthcare providers to be aware of roles they can play to achieve desired patient outcomes.

This module explores the 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain through case presentations and summaries, and includes many useful tools to help manage, assess and monitor patients using opioid therapy for chronic non-cancer pain.

After completing this course, you will be able to:

  1. Identify patients with chronic non-cancer pain (CNCP) who may benefit from a trial of opioid therapy, as well as identify those who should not start a trial of opioid therapy.
  2. Discuss the decision process involved when considering a trial of opioid therapy.
  3. Describe the potential risks/harms associated with opioids and outline how to discuss these issues with the patient.
  4. Describe what a trial of opioid therapy involves.
  5. Cite examples of when opioids should be rotated, tapered or stopped.
  6. Identify resources available to help you and your patients manage their CNCP.

Funds in support of this CPD activity were provided as an educational grant to Memorial University and independently allocated and disbursed in accordance with current CMA guidelines. Funds in support of this program were provided by McMaster University through a grant from Health Canada.

Course Registration

Opioids for Chronic Non-Cancer Pain: Using the Canadian Guideline in Your Practice

MDcme (on behalf of its consortium partners) protects the privacy of personal and other information regarding course registrants. MDcme will not release personally identifiable information to a third party without an individual's consent, except such information as is required for reporting purposes to the body or bodies accrediting this course for continuing education study credits. MDcme collects and reviews all course data (registration/course completion statistics, pre/post-test and satisfaction survey) to determine if a course meets participants' learning needs. Data is reviewed to improve existing courses and to inform the development of future course offerings. If an evaluation report is provided to a third party, all data is summarized, with no participant identifying information included. Given the importance and potential impact of some courses, evaluation data may be presented and/or published in academic venues. Again, this data is always summarized, with no identifying information included.

At times, a contributing/partner organization involved in a course may request individual participant data from pre/post or evaluation surveys for quality improvement or educational research purposes. This data would be de-identified so would not be associated with any personally identifiable information such as your name, profession, city, etc.

If requested by a contributing/partner organization:

Do you consent to the release of your individual, de-identified pre/post or evaluation survey data for the purposes of quality improvement or educational research?


You must have an account and be logged in to register for this course


Expiry Date

This course expires on
Friday, November 9, 2018